Mirabella Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,262
Closed -$247K 806
2026
Q1
$247K Buy
+1,262
New +$245K 0.02% 634
2024
Q1
Sell
-3,679
Closed -$507K 557
2023
Q4
$507K Buy
+3,679
New +$484K 0.07% 202
2023
Q1
Sell
-31,366
Closed -$4.91M 438
2022
Q4
$4.91M Buy
+31,366
New +$4.51M 0.44% 35
2022
Q3
Sell
-12,473
Closed -$1.66M 385
2022
Q2
$1.66M Sell
12,473
-8,352
-40% -$1.14M 0.16% 133
2022
Q1
$2.85M Buy
+20,825
New +$2.9M 0.32% 54
2021
Q4
Sell
-1,797
Closed -$261K 450
2021
Q3
$261K Sell
1,797
-1,457
-45% -$213K 0.03% 343
2021
Q2
$429K Buy
+3,254
New +$426K 0.08% 179
2021
Q1
Sell
-58,000
Closed -$6.91M 320
2020
Q4
$6.91M Buy
+58,000
New +$7.07M 0.86% 39

Other funds holding DGX

Mirabella Financial Services's DGX Position: Q2 2026 in Review

Mirabella Financial Services sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 1,262 shares — an estimated $247K sold.

Mirabella Financial Services first reported a position in DGX in Q4 2020 and held it in 8 quarters. The position peaked at $6.91M in Q4 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Mirabella Financial Services reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 1,262 Quest Diagnostics shares in Q2 2026, an estimated $247K.
  • Mirabella Financial Services first reported a position in Quest Diagnostics in Q4 2020 and held it in 8 quarters.
  • Mirabella Financial Services's Quest Diagnostics position peaked at $6.91M in Q4 2020.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.